Article Sidebar
Main Article Content
Abstract
patients with pustular psoriasis compared to those with psoriasis vulgaris and
healthy controls. The aim was to assess the potential role of procalcitonin as a
marker for inflammation and disease severity. The study was conducted at Al
Nasiriyah Teaching Hospital from March 2023 to October 2024, with diagnoses
confirmed by histopathological examination. The results demonstrated significant
differences in procalcitonin levels among the groups, suggesting a potential role
for corticosteroids in modulating systemic inflammation in psoriasis.
Keywords
Article Details
Copyright (c) 2025 Ahmed Abdulhussein Kawen , Saddam Sahib Atshan, Ahmed Sadek
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
- Liu, L., et al. (2020). Procalcitonin as a biomarker of inflammation in autoimmune diseases. Clinical and Experimental Dermatology,
- (6), 877-883.
- Papadavid, E., et al. (2022). Effect of corticosteroids on inflammatory markers in psoriasis: A systematic review. Journal of
- Dermatological Treatment, 33(6), 845-852.
- Gupta, A., et al. (2021). Effect of systemic corticosteroids on serum markers in psoriasis: A randomized trial. International Journal
- of Dermatology, 60(7), 804-811.
- Gonzalez, M., et al. (2020). Systemic effects of psoriasis and the role of corticosteroids in inflammatory modulation. Archives of
- Dermatological Research, 313(5), 257-265.
- Chao, C., & Lee, L. (2023). Psoriasis and inflammation: A systematic review of serum biomarkers and clinical outcomes.
- Dermatology Clinics, 41(2), 207-215.
- Nash, P., & Sorensen, L. (2021). Procalcitonin as a potential marker for systemic inflammation in dermatologic diseases. Journal
- of Autoimmunity and Inflammation, 36(3), 78-85.
- Varga, J., et al. (2021). Corticosteroids and their impact on biomarkers in dermatological diseases: An evidence-based approach.
- Dermatology and Therapy, 11(2), 128-134.
- Bastien, M., et al. (2022). The effect of systemic treatment on biomarkers in psoriasis: Corticosteroids and beyond. Journal of
- Clinical Dermatology, 57(5), 789-798.
- Kawen, A. A., & Jaaz, M. H. (2024). Ocular manifestations in psoriasis of Iraqi patients. Journal of Pakistan Association of
- Dermatologists, 34(2), 453-457.
- Wu, L., et al. (2023). Effect of corticosteroids on procalcitonin levels in patients with inflammatory skin diseases. Journal of
- Dermatological Science, 92(4), 303-310.
References
Liu, L., et al. (2020). Procalcitonin as a biomarker of inflammation in autoimmune diseases. Clinical and Experimental Dermatology,
(6), 877-883.
Papadavid, E., et al. (2022). Effect of corticosteroids on inflammatory markers in psoriasis: A systematic review. Journal of
Dermatological Treatment, 33(6), 845-852.
Gupta, A., et al. (2021). Effect of systemic corticosteroids on serum markers in psoriasis: A randomized trial. International Journal
of Dermatology, 60(7), 804-811.
Gonzalez, M., et al. (2020). Systemic effects of psoriasis and the role of corticosteroids in inflammatory modulation. Archives of
Dermatological Research, 313(5), 257-265.
Chao, C., & Lee, L. (2023). Psoriasis and inflammation: A systematic review of serum biomarkers and clinical outcomes.
Dermatology Clinics, 41(2), 207-215.
Nash, P., & Sorensen, L. (2021). Procalcitonin as a potential marker for systemic inflammation in dermatologic diseases. Journal
of Autoimmunity and Inflammation, 36(3), 78-85.
Varga, J., et al. (2021). Corticosteroids and their impact on biomarkers in dermatological diseases: An evidence-based approach.
Dermatology and Therapy, 11(2), 128-134.
Bastien, M., et al. (2022). The effect of systemic treatment on biomarkers in psoriasis: Corticosteroids and beyond. Journal of
Clinical Dermatology, 57(5), 789-798.
Kawen, A. A., & Jaaz, M. H. (2024). Ocular manifestations in psoriasis of Iraqi patients. Journal of Pakistan Association of
Dermatologists, 34(2), 453-457.
Wu, L., et al. (2023). Effect of corticosteroids on procalcitonin levels in patients with inflammatory skin diseases. Journal of
Dermatological Science, 92(4), 303-310.